Full video transcriptClick to expand
Auto-generated transcript of @iamseanchristopher's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Forget ozum pick because olive oil does the exact same thing literally the exact same thing
- 0:06But here's the crazy part
- 0:07Did you know that most of the olive oil that you buy in the store is actually fake?
- 0:10It's actually vegetable oil 80% of the olive oil is fake. You can actually look this up. It's very public information
- 0:16It's freaking crazy. So watch this video to the end because I'm gonna tell you what to do about that too
- 0:20So the reason why olive oil does the same thing is because it impacts the GOP one hormone in the body in the exact same way
- 0:27It was those epic does literally the exact same way
- 0:30So yes, you can use olive oil and get the same results as you get with a zimpeh
- 0:35So all these different olive oils that you see on the shelf right here literally 80% of them are completely fake
- 0:41It's disgusting
- 0:43So if you visit my website a life folio live calm
- 0:46You can see a link to my blog right there that blog has an article on it that explains olive oil
- 0:51And I also explained you how to determine whether or not your olive oil is fake
Does olive oil really work like Ozempic? A fact-check
Quick answer
Olive oil contains oleic acid, which stimulates intestinal GLP-1 secretion through free fatty acid receptors GPR119 and GPR40 after meals, a real but transient and modest effect. Semaglutide, the active ingredient in Ozempic, is a GLP-1 receptor agonist with a 7-day half-life that produces sustained pharmacological receptor activation, a fundamentally different mechanism and magnitude of action. Patients managing type 2 diabetes or obesity should not substitute prescribed GLP-1 therapy with dietary changes without consulting their prescribing clinician.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Compounded Semaglutide access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Does olive oil really work like Ozempic? A fact-check, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this semaglutide video claims cluster
Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Does olive oil really work like Ozempic? A fact-check" from iamseanchristopher. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Olive oil contains oleic acid, which stimulates intestinal GLP-1 secretion through free fatty acid receptors GPR119 and GPR40 after meals, a real but transient and modest effect.
The reason this review is not generic is the source wording and the canonical claim label "glp1 olive oil particularly extra virgin olive oil supports glp 1." In this clip, the useful excerpt is: "Forget ozum pick because olive oil does the exact same thing literally the exact same thing But here's the crazy part Did you know that most of the olive oil that you buy in the store is actually fake?" That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Olive oil contains oleic acid, which stimulates intestinal GLP-1 secretion through free fatty acid receptors GPR119 and GPR40 after meals, a real but transient and modest effect.
FormBlends verdict
Compounded Semaglutide safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Olive oil contains oleic acid, which stimulates intestinal GLP-1 secretion through free fatty acid receptors GPR119 and GPR40 after meals, a real but transient and modest effect. Semaglutide, the active ingredient in Ozempic, is a GLP-1 receptor agonist with a 7-day half-life that produces sustained pharmacological receptor activation, a fundamentally different mechanism and magnitude of action. Patients managing type 2 diabetes or obesity should not substitute prescribed GLP-1 therapy with dietary changes without consulting their prescribing clinician.
- Oleic acid in olive oil activates GPR119 and GPR40 receptors, producing a measurable but meal-dependent and short-lived bump in GLP-1 secretion (Steinert et al., 2017, Nutrients).
- Semaglutide has a 165-hour half-life and produces continuous GLP-1 receptor activation at pharmacological concentrations. Olive oil does not do this.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.
Review Compounded SemaglutideWhat You'll Learn
- Oleic acid in olive oil activates GPR119 and GPR40 receptors, producing a measurable but meal-dependent and short-lived bump in GLP-1 secretion (Steinert et al., 2017, Nutrients).
- Semaglutide has a 165-hour half-life and produces continuous GLP-1 receptor activation at pharmacological concentrations. Olive oil does not do this.
- In the STEP 1 trial, semaglutide 2.4mg produced average 14.9% body weight loss over 68 weeks (Wilding et al., 2021, NEJM). No olive oil trial has shown comparable results.
- The PREDIMED trial (Estruch et al., 2013, NEJM) confirmed a Mediterranean diet including olive oil reduces cardiovascular risk. Olive oil is healthy. It is not a drug replacement.
- A 2010 UC Davis study found 69% of imported extra virgin olive oils tested failed international grade standards, mostly due to oxidation or mislabeling, not wholesale vegetable oil substitution.
- The 80% fake olive oil figure the creator cites appears unsourced and is not consistent with published adulteration research. It functions more as an attention hook than a cited data point.
- Anyone currently prescribed a GLP-1 receptor agonist should not stop or modify their medication based on dietary advice from social media without speaking to their prescriber.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @iamseanchristopher actually say?
The creator's core claim is direct: "forget ozum pick because olive oil does the exact same thing literally the exact same thing." He argues olive oil impacts the GLP-1 hormone "in the exact same way" as semaglutide, meaning you can "get the same results" as Ozempic just by using olive oil. He also claims 80% of store-bought olive oil is fake, replaced with vegetable oil, and points viewers to his website for more details.
To be clear about what he's asserting: this isn't "olive oil may support GLP-1 activity." He's saying full equivalency. Same mechanism. Same results. That's an extraordinary claim, and extraordinary claims require extraordinary evidence. He doesn't cite a single study. Not one.
Does the science back this up?
No. Olive oil has measurable effects on GLP-1 secretion, but calling it equivalent to semaglutide is not supported by any published evidence. The two work through completely different biological pathways, and the magnitude of effect is not remotely comparable.
Here's what the research actually shows: dietary fats, including oleic acid from olive oil, do stimulate GLP-1 release from intestinal L-cells after a meal. Rocca and Brubaker (1999, American Journal of Physiology) confirmed fat intake triggers GLP-1 secretion. More recently, Steinert et al. (2017, Nutrients) showed that oleic acid specifically activates free fatty acid receptors GPR119 and GPR40, which are involved in incretin hormone release.
But semaglutide is a GLP-1 receptor agonist. It binds directly to GLP-1 receptors with a half-life of about 7 days and produces sustained, pharmacological-level GLP-1 receptor activation. A drizzle of olive oil produces a transient, meal-dependent bump in endogenous GLP-1 that lasts hours and varies widely by individual. These are not the same mechanism. At all.
What did they get wrong (or right)?
Wrong on the big claim: olive oil is not equivalent to Ozempic. Saying it works "literally the exact same way" is false. Semaglutide produces HbA1c reductions of 1.5-2% and average weight loss of 12-15% of body weight in clinical trials (Wilding et al., 2021, NEJM). No dietary fat intervention comes close to those outcomes in comparable populations.
Partially right on the mechanism: olive oil does interact with GLP-1 pathways. That part isn't invented. But "interacts with" and "does the same thing as a GLP-1 receptor agonist drug" are completely different statements.
The 80% fake olive oil claim is also worth scrutinizing. There have been real adulteration scandals in the olive oil industry. A 2010 UC Davis study found that 69% of imported extra virgin olive oils tested failed to meet international standards. That's a genuine issue. But "80% is fake vegetable oil" overstates what the evidence shows, and the creator doesn't source where that specific number comes from. It reads more like a hook to sell something on his website than a sober assessment of the literature.
What should you actually know?
If you're managing blood sugar or weight, the relevant distinction here matters. A Mediterranean diet pattern that includes olive oil has real, documented benefits for metabolic health. Estruch et al. (2013, NEJM) showed the PREDIMED diet reduced cardiovascular events meaningfully. Olive oil is a genuinely healthy fat. Eat it.
But if you or someone you care about has type 2 diabetes or obesity and is considering whether olive oil is a real substitute for prescribed GLP-1 therapy, the answer from the evidence is no. They do not produce the same clinical outcomes. Replacing a medication with a food based on a TikTok video is a decision that should involve your doctor, not a content creator selling blog traffic.
- Olive oil supports GLP-1 activity as part of normal digestion. That's real.
- Semaglutide is a pharmaceutical that activates GLP-1 receptors directly and continuously. That's different.
- No peer-reviewed trial has shown olive oil produces weight loss or glycemic control equivalent to GLP-1 receptor agonists.
- The olive oil adulteration issue is real but the 80% figure is unsourced.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
iamseanchristopher · TikTok creator
123.1K views on this video
Olive oil, particularly extra virgin olive oil, supports GLP-1 activity in a way similar to Ozempic by stimulating its natural release and enhancing its effects in the body. The healthy monounsaturated fats in olive oil slow gastric emptying, which helps stabilize blood sugar levels and prolong feelings of fullness. This process indirectly promotes GLP-1 secretion. Additionally, olive oil contains bioactive compounds, like polyphenols, that support gut health by fostering beneficial gut bacteri
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about oleic acid in olive oil activates gpr119?
Oleic acid in olive oil activates GPR119 and GPR40 receptors, producing a measurable but meal-dependent and short-lived bump in GLP-1 secretion (Steinert et al., 2017, Nutrients).
What does the video say about semaglutide has a 165-hour half-life?
Semaglutide has a 165-hour half-life and produces continuous GLP-1 receptor activation at pharmacological concentrations. Olive oil does not do this.
What does the video say about in the step 1 trial, semaglutide 2.4mg produced average 14.9%?
In the STEP 1 trial, semaglutide 2.4mg produced average 14.9% body weight loss over 68 weeks (Wilding et al., 2021, NEJM). No olive oil trial has shown comparable results.
What does the video say about the predimed trial (estruch et al., 2013, nejm) confirmed a?
The PREDIMED trial (Estruch et al., 2013, NEJM) confirmed a Mediterranean diet including olive oil reduces cardiovascular risk. Olive oil is healthy. It is not a drug replacement.
What does the video say about a 2010 uc davis study found 69% of imported extra?
A 2010 UC Davis study found 69% of imported extra virgin olive oils tested failed international grade standards, mostly due to oxidation or mislabeling, not wholesale vegetable oil substitution.
What does the video say about the 80% fake olive oil figure the creator cites appears?
The 80% fake olive oil figure the creator cites appears unsourced and is not consistent with published adulteration research. It functions more as an attention hook than a cited data point.
Sources & references
- [1]Steinert et al. (2017)
- [2]Wilding et al., 2021
- [3]Estruch et al. (2013)
- [4]Rocca and Brubaker (1999)
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by iamseanchristopher, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.